期刊
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
卷 45, 期 -, 页码 184-195出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jddst.2018.03.015
关键词
Metformin hydrochloride; Complex coacervation; Double emulsion; Response surface methodology (RSM); Soybean protein isolate (SPI); Pectin
Metformin hydrochloride is a biguanide antihyperglycemic agent, widely used in the management of non-insulin dependent diabetes mellitus (type 2), it has a short biological half-life of 1.5-1.6 h, and its daily requirement is 1.5-3 g/day with an absolute bioavailability of 50-60%, when administered orally. However some gastro-in-testinal symptoms, like abdominal discomfort, nausea and diarrhea may occur during the treatment. This study was carried out to optimize conditions for metformin microencapsulation by complex coacervation using response surface methodology (RSM). Sunflower oil was used to obtain the primary emulsion, whereas the coating materials of microencapsulation were soybean protein isolate (SPI) and pectin. For the complex coacervation process, soy lecithin and Tween 80 were used as surfactants to enhance W/O/W double emulsion stability. Thus, double emulsion followed by complex coacervation is studied. The microencapsulation of metformin under the optimized conditions ensures the mean size of 16 mu m of microcapsules combined with the narrow size distribution of 1.3 (span) and the highest yield reaching up to 84%. These results show that complex coacervation using SPI/pectin as wall material was an efficient method which have never been reported in literature as microencapsulation process of metformin hydrochloride.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据